Literature DB >> 12420880

Advanced glycation end-products/peptides: a preliminary investigation by LC and LC/MS.

Annunziata Lapolla, Domenico Fedele, Antonella Senesi, Nadia Concetta Arico, Rachele Reitano, Roberta Seraglia, Hubert Astner, Pietro Traldi.   

Abstract

An investigation on AGE-peptides, originating by proteolysis of in vitro glycated proteins, was carried out by LC methods with different detection applied to the mixture produced by proteinase K digestion of in vitro glycated human serum albumin (HSA). Classical approaches, like spectroscopic (UV, fluorescence) and mass spectrometric methods (MALDI, LC/ESI/MS), show that the digestion mixture is highly complex. However, there are clearcut differences between the digestion mixtures of glycated and unglycated HSA, in the former case allowing identification of possible glycated peptides belonging to the AGE-peptide class. MS/ MS experiments on selected species seem to be promising as regards structural information.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12420880     DOI: 10.1016/s0014-827x(02)01305-8

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  3 in total

1.  Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides.

Authors:  Annunziata Lapolla; Domenico Fedele; Rachele Reitano; Nadia Concetta Aricò; Roberta Seraglia; Pietro Traldi; Ester Marotta; Roberto Tonani
Journal:  J Am Soc Mass Spectrom       Date:  2004-04       Impact factor: 3.109

2.  Mass spectrometric characterization of glycated beta-lactoglobulin peptides derived from galacto-oligosaccharides surviving the in vitro gastrointestinal digestion.

Authors:  F Javier Moreno; Jesús Eduardo Quintanilla-López; Rosa Lebrón-Aguilar; Agustín Olano; María Luz Sanz
Journal:  J Am Soc Mass Spectrom       Date:  2008-04-10       Impact factor: 3.109

Review 3.  Maillard Proteomics: Opening New Pages.

Authors:  Alena Soboleva; Rico Schmidt; Maria Vikhnina; Tatiana Grishina; Andrej Frolov
Journal:  Int J Mol Sci       Date:  2017-12-12       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.